A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors
Recruiting
N/A
Interventional Study
Ocular Tumor
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 60 (estimated)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to compare two devices used for optical coherence tomography (OCT). OCT is a noninvasive imaging (scanning) method that uses reflected light to create pictures of the back of the eye, and doctors can use OCT to detect and monitor different types of cancer
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥18 years.
* At least 1 eye that has an intraocular or ocular surface tumor.
* The presence of a natural crystalline lens or intraocular lens.
* Pupils that can dilate up to at least 3 mm in the study eyes.
* The absence of opaque natural crystalline lenses or the presence…
Contacts